Sep 03, 2020 3:17pm EDT Mydecine Innovations Group Would Like to Give Thanks to its Shareholders for Extending the Lockup on the Five Cent Placement for Another 120 Days
Aug 18, 2020 7:30am EDT Mydecine™ Launches World's First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise
Aug 13, 2020 7:37am EDT Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD
Aug 12, 2020 7:30am EDT Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector
Aug 04, 2020 7:30am EDT Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness
Jul 27, 2020 9:22am EDT Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO
Jul 24, 2020 5:21pm EDT Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO
Jul 21, 2020 7:30am EDT Mindleap Health Signs Agreement with Brightmind to Launch Comprehensive Meditation Program
Jul 16, 2020 7:30am EDT Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute